Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of osteoarthritis
3.2.1.2 Growing geriatric population
3.2.1.3 Rising demand for minimally invasive procedures
3.2.1.4 Technological advancements in HA-based products
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Potential adverse reactions and side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Multiple injection dose
5.3 Single injection dose
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Dermal fillers
6.3 Osteoarthritis
6.4 Ophthalmic
6.5 Vesicoureteral reflux
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By Grade, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Cosmetic grade hyaluronic acid
7.3 Pharmaceutical grade hyaluronic acid
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Dermatology clinics
8.4 Ambulatory surgical centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Allergan, Inc.
10.2 Anika Therapeutics, Inc.
10.3 Bloomage Biotech Co., Ltd
10.4 F. Hoffmann-La Roche Ltd
10.5 Ferring B.V.
10.6 GALDERMA
10.7 LG Chem, Ltd.
10.8 Lifecore Biomedical, Inc.
10.9 Salix Pharmaceuticals, Ltd.
10.10 Sanofi
10.11 Seikagaku Corporation
10.12 Zimmer Biomet
